Pfizer Inc. — Balance Sheet Charts
75 snapshots of history · ending 2026-03-29 · SEC EDGAR
Assets vs Liabilities
Cash Position Breakdown
Debt Structure
Working Capital Components
Capital Structure (LT Debt / Cash / Equity)
Pfizer Inc. — Equity RollforwardNEW
Per-period stockholders' equity flows + ending balances by component, sourced from the issuer's 10-K dimensional XBRL on us-gaap:StatementEquityComponentsAxis. Positive flows (Net Income / OCI / SBC / Stock Issuance) above the axis; negative flows (Dividends / Buybacks / Tax Withholding) below. Net change in equity per period = sum of bars.
Common + APIC
$95.0B
↑ 0.9%
Retained Earnings
$114.6B
↓ 1.8%
AOCI
−$8.1B
↓ 2.9%
Treasury Stock
−$115.0B
↓ 0.2%
NCI
$299.0M
↑ 1.7%
Total Equity
—
Pfizer Inc. — Long-Term Debt ScheduleNEW
Per-bond schedule sourced from us-gaap:DebtInstrumentAxis dimensional XBRL. Stated rates converted from XBRL's decimal convention (e.g. 0.052) to percent (5.20%).
Total Face
$9.30B
Total Carrying
$61.29B
Weighted Avg Rate
4.02%
| Instrument | Stated Rate | Face | Carrying | Effective Rate |
|---|---|---|---|---|
| Senior Unsecured Notes4.500 Due November2032 | 4.50% | $1.25B | — | — |
| Senior Unsecured Notes4.875 Due November2035 | 4.88% | $1.25B | — | — |
| Senior Unsecured Notes3.875 Due November2027 | 3.88% | $1.00B | — | — |
| Senior Unsecured Notes4.200 Due November2030 | 4.20% | $1.00B | — | — |
| Senior Unsecured Notes3.250 Due May2032 | 3.25% | $1.00B | — | — |
| Senior Unsecured Notes4.250 Due May2045 | 4.25% | $800.0M | — | — |
| Senior Unsecured Notes2.875 Due May2029 | 2.88% | $750.0M | — | — |
| Senior Unsecured Notes3.875 Due May2037 | 3.88% | $750.0M | — | — |
| Senior Unsecured Notes Due November2027 | 0.50% | $500.0M | $500.0M | — |
| Senior Unsecured Notes5.600 Due November2055 | 5.60% | $500.0M | — | — |
| Senior Unsecured Notes5.700 Due November2065 | 5.70% | $500.0M | — | — |
| Senior Unsecured Debt Due20512065 | — | — | $11.00B | 5.30% |
| Senior Unsecured Debt Due20362040 | — | — | $10.46B | 5.30% |
| Senior Unsecured Debt Due20312035 | — | — | $10.42B | 4.40% |
| Senior Unsecured Debt Due20412045 | — | — | $7.54B | 4.30% |
| Senior Unsecured Debt Due2030 | — | — | $6.25B | 3.70% |
| Senior Unsecured Debt Due2028 | — | — | $5.66B | 4.60% |
| Senior Unsecured Debt Due20462050 | — | — | $4.75B | 3.70% |
| Senior Unsecured Debt Due2029 | — | — | $2.63B | 3.30% |
| Senior Unsecured Debt Due2027 | — | — | $2.08B | 2.90% |
| Senior Unsecured Debt Due2026 | 4.45% | — | — | — |
| Senior Unsecured Notes Due November20272065 | — | — | — | 4.58% |
| Senior Unsecured Notes Due May20292045 | — | — | — | 3.60% |
Pfizer Inc. — Pension & OPEBNEW
Per-plan-type defined-benefit + post-retirement disclosures sourced from us-gaap:RetirementPlanTypeAxis dimensional XBRL. Funded status (= plan assets − benefit obligation) is the headline signal — negative values mean the plan is underfunded and the gap sits on the balance sheet as hidden leverage. Discount-rate and expected-return assumptions drive the obligation calculation; small assumption changes cause large swings in the projected liability.
Pension Plans Defined Benefit
Plan Assets
$10.12B
Benefit Obligation
$9.59B
Funded Status
+$535.0M
Discount Rate
5.60%
Expected Return
7.70%
Net Periodic Cost
−$265.0M
Service Cost
$0
Interest Cost
$529.0M
Employer Contrib.
—
Funded Status Trend
Other Postretirement Benefit Plans Defined Benefit
Plan Assets
$814.0M
Benefit Obligation
$561.0M
Funded Status
+$253.0M
Discount Rate
5.20%
Expected Return
7.80%
Net Periodic Cost
−$155.0M
Service Cost
$17.0M
Interest Cost
$25.0M
Employer Contrib.
—
Funded Status Trend
Pfizer Inc. — Hedging ActivityNEW
Per-axis derivative-disclosure decomposition sourced from us-gaap:HedgingDesignationAxis and us-gaap:DerivativeInstrumentRiskAxis dimensional XBRL. Designation tells the accounting treatment (designated = earnings volatility bypassed via OCI; nondesignated = mark-to-market through P&L). Risk class tells what's being hedged.
By Hedge Designation
Notional
$22.98B
Fair Value
$325.0M / $1.07B
Notional
$22.78B
Fair Value
$155.0M / $162.0M
| Member | Class | Notional | FV Asset | FV Liability | Gain / Loss |
|---|---|---|---|---|---|
| Designated As Hedging Instrument | Designated | $22.98B | $325.0M | $1.07B | — |
| Nondesignated | Nondesignated | $22.78B | $155.0M | $162.0M | +$98.0M |
By Risk Class
Notional
$22.98B
Fair Value
$325.0M / $1.07B
Notional
$6.75B
Fair Value
$52.0M / $230.0M
| Member | Class | Notional | FV Asset | FV Liability | Gain / Loss |
|---|---|---|---|---|---|
| Foreign Exchange Contract | Foreign Exchange | $22.98B | $325.0M | $1.07B | +$98.0M |
| Interest Rate Contract | Interest Rate | $6.75B | $52.0M | $230.0M | — |
Pfizer Inc. — PP&E by TypeNEW
Capitalized-asset breakdown sourced from us-gaap:PropertyPlantAndEquipmentByTypeAxis dimensional XBRL. Surfaces the "where capex is flowing" story — servers/networking dominate cloud-infra builds (AMZN, META), upstream equipment dominates energy capex (XOM), vehicles/fleet dominate auto-OEMs (TSLA).
By CategoryAs of 2025-12-31 · Total Gross $36.70B
$16.14B
44.0% of total
$10.04B
27.4% of total
$5.71B
15.6% of total
$4.80B
13.1% of total
| Member | Class | Gross | Accum. Dep. | Net | Useful Life |
|---|---|---|---|---|---|
| Machinery And Equipment | Machinery & Equipment | $16.14B | — | — | — |
| Building | Land & Buildings | $9.74B | — | — | — |
| Furniture And Fixtures | Other | $5.71B | — | — | — |
| Construction In Progress | Construction in Progress | $4.80B | — | — | — |
| L and | Land & Buildings | $299.0M | — | — | — |
Pfizer Inc. — Pension Plan Asset AllocationNEW
Per-asset-category breakdown of the pension plan, sourced from us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis dimensional XBRL. Tells the de-risking story — mature plans shift from equity to fixed income as obligations approach payout. Target vs actual allocation column shows the rebalancing signal.
By CategoryAs of 2025-12-31 · Total Plan Assets $11.33B
| Category | Fair Value | Actual % | Target % | Δ vs Target |
|---|---|---|---|---|
| Other | $6.33B55.9% | — | 10.0% | — |
| Fixed Income / Debt | $2.70B23.9% | — | 45.0% | — |
| Equity Securities | $1.61B14.2% | — | 10.0% | — |
| Cash & Equivalents | $682M6.0% | — | 0.0% | — |